FDA Inspection 1048732 — Rogelio Amisola MD
The FDA completed an inspection of Rogelio Amisola MD on Mar 29, 2018 in Dayton, OH. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 29, 2018
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Dayton, OH (United States)
Additional Details
Clinical Investigator (CI)